E-LIB Suche - Ergebnisse für: Pegoraro, V.

1

PMH13 Healthcare Resources Utilization and Sick Leave Exper..:

Bonelli, A. ; Cattaneo, A. ; Comandini, A....
Value in Health. 23 (2020) - p. S586 , 2020

Link: https://doi.org/10.1016/..

2

What drives inhaler prescription for asthma patients? Resul..:

Lavorini, F. ; Bianco, A. ; Blasi, F....
Respiratory Medicine. 166 (2020) - p. 105937 , 2020

Link: https://doi.org/10.1016/..

3

PMS12 PATIENTS PRESCRIBED WITH OPIOID TREATMENT IN PRIMARY ..:

Peduto, I. ; Pegoraro, V. ; Cipelli, R..
Value in Health. 22 (2019) - p. S695-S696 , 2019

Link: https://doi.org/10.1016/..

4

PCV139 EUROPEAN SURVEY ON STABLE ANGINA: REAL WORLD INSIGHT..:

Heiman, F. ; Peduto, I. ; Pegoraro, V....
Value in Health. 22 (2019) - p. S567 , 2019

Link: https://doi.org/10.1016/..

5

Review: Danon disease: Review of natural history and recent..:

Cenacchi, G. ; Papa, V. ; Pegoraro, V....
Neuropathology and Applied Neurobiology. 46 (2019) 4 - p. 303-322 , 2019

Link: https://doi.org/10.1111/..

6

Update on polyglucosan storage diseases:

Cenacchi, Giovanna ; Papa, V. ; Costa, R....
Virchows Archiv. 475 (2019) 6 - p. 671-686 , 2019

Link: https://doi.org/10.1007/..

7

P.88Lipid storage myopathies due to ETFDH and PNPLA2 mutati..:

Angelini, C. ; Pegoraro, V. ; Marozzo, R....
Neuromuscular Disorders. 29 (2019) - p. S66 , 2019

Link: https://doi.org/10.1016/..

8

P.28Tracking cognitive changes in DM1 in a 5 year follow-up..:

Pinzan, E. ; Pegoraro, V. ; Marozzo, R..
Neuromuscular Disorders. 29 (2019) - p. S49 , 2019

Link: https://doi.org/10.1016/..

9

METABOLIC MYOPATHIES I:

Angelini, C. ; Marozzo, R. ; Pegoraro, V.
Neuromuscular Disorders. 28 (2018) - p. S113 , 2018

Link: https://doi.org/10.1016/..

10

PND6 - CHARACTERIZATION OF PREVENTIVE TREATMENT IN EPISODIC..:

Pegoraro, V ; Heiman, F ; di Nola, L...
Value in Health. 21 (2018) - p. S329-S330 , 2018

Link: https://doi.org/10.1016/..

11

PCV25 - LIPID MODIFYING THERAPY AND LDL-C ACHIEVEMENTS IN A..:

Gazzi, L. ; Fanelli, F. ; Heiman, F...
Value in Health. 21 (2018) - p. S96 , 2018

Link: https://doi.org/10.1016/..

12

PCV26 - LIPID MODIFYING THERAPY AND LDL-C ACHIEVEMENTS IN A..:

Fanelli, F. ; Gazzi, L. ; Heiman, F...
Value in Health. 21 (2018) - p. S96-S97 , 2018

Link: https://doi.org/10.1016/..

13

LGMD AUTOSOMAL RESSESSIVE AND DOMINANT:

Angelini, C. ; Marozzo, R. ; Pegoraro, V.
Neuromuscular Disorders. 28 (2018) - p. S62 , 2018

Link: https://doi.org/10.1016/..

14

Do Characteristics of Patients Influencing the Choice of Pa..:

Heiman, F ; Pegoraro, V
Value in Health. 20 (2017) 9 - p. A546 , 2017

Link: https://doi.org/10.1016/..

15

Chemotherapy-induced nausea and vomiting (CINV) in patients..:

Carnio, S. ; Galetta, D. ; Scotti, V....
Supportive Care in Cancer. 26 (2017) 6 - p. 1841-1849 , 2017

Link: https://doi.org/10.1007/..